Study Management Blog

BiotechClimbClimbCRODiscoveryPharmaceuticalPre-ClinicalStudy ManagementWorkflow Automation

Modernizing Non-GLP Study Management With Climb™ | Webinar Recap

Instem Team

During the webinar, we took a look at the Climb interface to see how practical workflows drive improved study efficiency, accuracy, and coordination. If you want to see Climb in action, be sure to check...

BiotechClimbClimbCROData IntegrationPharmaceuticalPharmacokinetics and PharmacodynamicsPre-ClinicalRegulatory ComplianceRegulatory SubmissionRegulatory SubmissionsResearch CollaborationSENDSEND Advantage ServicesStudy ManagementToxicologyWorkflow Automation

Generating SEND from Climb™

Instem Team

Non-GLP studies that support regulatory safety decisions are required by the FDA to be submitted in SEND, regardless of GLP status. Data collected in Climb™ can be efficiently converted into submission-ready SEND using Instem’s Submit™...

Stay up to Date

Get expert tips, industry news, and fresh content delivered to your inbox.